DermTech, Inc.
DMTKQ · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $15 | $15 | $12 | $6 |
| % Growth | 5.4% | 22.6% | 101.2% | – |
| Cost of Goods Sold | $15 | $14 | $11 | $6 |
| Gross Profit | $0 | $1 | $1 | -$0 |
| % Margin | 1.8% | 4.5% | 10.8% | -1.6% |
| R&D Expenses | $15 | $24 | $16 | $5 |
| G&A Expenses | $44 | $36 | $25 | $14 |
| SG&A Expenses | $89 | $95 | $62 | $30 |
| Sales & Mktg Exp. | $45 | $59 | $38 | $16 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $104 | $119 | $79 | $35 |
| Operating Income | -$104 | -$118 | -$77 | -$35 |
| % Margin | -678.2% | -813.9% | -653.8% | -599.6% |
| Other Income/Exp. Net | $3 | $1 | -$1 | -$1 |
| Pre-Tax Income | -$101 | -$117 | -$78 | -$36 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$101 | -$117 | -$78 | -$36 |
| % Margin | -659.6% | -803.7% | -661.7% | -619.8% |
| EPS | -3.09 | -3.88 | -2.71 | -2.15 |
| % Growth | 20.4% | -43.2% | -26% | – |
| EPS Diluted | -3.09 | -3.88 | -2.71 | -2.15 |
| Weighted Avg Shares Out | 33 | 30 | 29 | 17 |
| Weighted Avg Shares Out Dil | 33 | 30 | 29 | 17 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $1 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $6 | $4 | $2 | $0 |
| EBITDA | -$98 | -$114 | -$75 | -$35 |
| % Margin | -640% | -783.2% | -634.4% | -591.4% |